Biologists one step closer to neutralizing HIV
Researchers around the world have been studying a group of recently-identified antibodies capable of neutralizing most strains of HIV, with the hopes of developing a vaccine that produces antibodies with these same properties.
Now, biologists out of the California Institute of Technology--led by Nobel Laureate David Baltimore--are one step closer to a vaccine with their new method of delivering these antibodies to lab mice, thereby protecting them from HIV.
Their approach, called Vectored ImmunoProphylaxis (VIP) and outlined in today's online issue of Nature, turns the traditional vaccination method on its head.
For the most part, researchers have focused … Read more